MODERN POSSIBILITIES AND EFFECTIVENESS OF VACCINE PREVENTION OF PNEUMOCOCCAL INFECTION IN CHILDREN

MODERN POSSIBILITIES AND EFFECTIVENESS OF VACCINE PREVENTION OF PNEUMOCOCCAL INFECTION IN CHILDREN

Pneumococcal infection is one of the leading reasons of the infection incidence and mortality rates. The pneumococcal infection has special danger for infants and elderly persons [1--7]. Thus, in children aged under 5 pneumococcus is one of the five causative agents accounting for the half of all le...

Full description

Bibliographic Details
Main Authors:	A. L. Zaplatnikov, A. A. Girina, I. V. Lepiseva
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	pneumococcal infection children community-acquired pneumonia vaccine prevention
Online Access:	https://www.med-sovet.pro/jour/article/view/1508

Similar Items

The Results of a Three-Year Pneumococcal Vaccination of Children in Russia
by: Nikolay I. Briko, et al.
Published: (2018-10-01)

Efficacy of conjugate vaccines in pneumococcal infection prevention
by: A. L. Perova, et al.
Published: (2014-09-01)

Vaccine Prevention of Pneumococcal Infection in Children
by: Alexander A. Baranov, et al.
Published: (2018-07-01)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>
by: Thomas Chandler, et al.
Published: (2022-03-01)

Vaccinal Prevention of Lower Respiratory Tract Pneumococcal Disease in Adults Without Immunosuppression
by: I. A. Guchev
Published: (2020-05-01)

The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
by: O. N. Lesina, et al.
Published: (2019-04-01)

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE EFFECTIVENESS OF VACCINATION OF CHILDREN AGAINST PNEUMOCOCCAL INFECTION IN THE AMUR REGION
by: A. G. Chuchalin, et al.
Published: (2016-06-01)

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia
by: Ching-Fen Shen, et al.
Published: (2020-08-01)

Decrease of Pneumococcal Community-Acquired Pneumonia Hospitalization and Associated Complications in Children after the Implementation of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in Taiwan
by: Ching-Fen Shen, et al.
Published: (2021-09-01)

VACCINE PREVENTION OF PNEUMOCOCCAL INFECTIONS IN ADULTS
by: A. A. Zaitsev, et al.
Published: (2017-11-01)

The remaining challenges of pneumococcal disease in adults
by: E. Ludwig, et al.
Published: (2012-03-01)

Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016–2018—The ECAPS study
by: Karin Hansen, et al.
Published: (2023-02-01)

Vaccinal Prevention of Pneumococcal Infection in Children
by: A. A. Baranov, et al.
Published: (2015-12-01)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
by: Sanath Thushara Kudagammana, et al.
Published: (2020-08-01)

Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany
by: Felicitas Kühne, et al.
Published: (2023-12-01)

Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
by: Rosario Menéndez, et al.
Published: (2023-11-01)

Pneumococcal Disease: Global Disease Prevention Strategies with a Focus on the Challenges in Iraq
by: Al-Jumaili A, et al.
Published: (2023-05-01)

PNEUMOCOCCAL INFECTION IN CHILDREN: EVERYDAY PRACTICE
by: L. S. Namazova-Baranova, et al.
Published: (2012-07-01)

Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines
by: Echániz-Avilés Irma Gabriela, et al.
Published: (2001-01-01)

Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>. <i>Microorganisms</i> 2022, <i>10</i>, 560
by: Nicole Cossrow, et al.
Published: (2022-10-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
by: N. L. Chernaya, et al.
Published: (2013-01-01)

Haemophilus influenzae type b and pneumococcal conjugate vaccination coverage in children aged 2-59 months in Malawi
by: Daphne Gadama, et al.
Published: (2021-02-01)

A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United Kingdom
by: James Campling, et al.
Published: (2023-12-01)

PROPHYLACTIC EFFICACY OF VACCINATION AGAINST PNEUMOCOCCAL INFECTION IN CHILDREN WITH CHRONIC ADENOTONSILLAR DISEASES
by: S. N. Beniova, et al.
Published: (2015-08-01)

Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines
by: Oana Falup-Pecurariu
Published: (2012-12-01)

THE EXPERIENCE OF PNEUMOCOCCAL CONJUGATE VACCINE USAGE IN ORPHANAGE INSTITUTION OF THE REPUBLIC OF MORDOVIA
by: A. A. Brovkina, et al.
Published: (2012-11-01)

Pneumococcal conjugate vaccine in HIV-infected and HIV-exposed, uninfected children
by: Sabelle Jallow, et al.
Published: (2017-05-01)

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective
by: Weil-Olivier Catherine, et al.
Published: (2012-09-01)

Effectiveness of 13-valent pneumococcal polysaccharide conjugate vaccine on community-acquired pneumonia: a retrospective cohort study among young children in Suzhou city
by: Zhao-jin LI, et al.
Published: (2022-11-01)

Pneumonia: Regional experience with prevention programs
by: A G Chuchalin, et al.
Published: (2016-08-01)

Estimation of 13-valent Pneumococcal Conjugate Vaccine Efficiency in Infants within National Immunization Schedule
by: Nikolay I. Briko, et al.
Published: (2019-09-01)

Modern Approaches to Vaccinal Prevention of a Pneumococcal Infection in Adults Patients with Diabetes Mellitus (Literature Review)
by: J. A. Paramonova, et al.
Published: (2018-04-01)

Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus “no vaccination” and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
by: Miguel Gouveia, et al.
Published: (2019-04-01)

Adult vaccination against respiratory infections in Egypt: a review of expert opinions
by: Ashraf Madkour, et al.
Published: (2024-12-01)

Observed costs and health care use of children in a prospective cohort study on community-acquired pneumonia in Geneva, Switzerland
by: Kristina Keitel, et al.
Published: (2014-03-01)

Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to Hajj pilgrims
by: Dilip Mathai, et al.
Published: (2016-01-01)

Clinical Efficacy of Pneumococcal Conjugate 13-valent Vaccine in Young Children
by: S. M. Kharit, et al.
Published: (2016-12-01)

PCV13 Vaccination of Adults against Pneumococcal Disease: What We Have Learned from the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA)
by: Christian Theilacker, et al.
Published: (2022-01-01)

Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey
by: Erdem Gönüllü, et al.
Published: (2020-10-01)

EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE: EMERGING DATA FROM INVASIVE PNEUMOCOCCAL DISEASE, PNEUMONIA, ACUTE OTITIS MEDIA AND NASOPHARYNGEAL CARRIAGE
by: Ralf Rene Reinert, et al.
Published: (2012-06-01)